Cytovale® Announces Commercial Launch of IntelliSep® Sepsis Test, the First-of-its-Kind Diagnostic Tool for Emergency Departments

SAN FRANCISCO, August 01, 2023--Cytovale®, a pioneering medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, announced today the U.S. commercial launch of the IntelliSep® sepsis test following FDA 510(k) clearance in December 2022. Our Lady of the Lake Regional Medical Center in Baton Rouge, Louisiana, is the first U.S. medical center to adopt IntelliSep for emergency department (ED) use. The test aids in the rapid di

Related Keywords

United States ,Baton Rouge ,Louisiana ,Mississippi ,Hollis Oneal ,Weber Shandwick ,Our Lady ,Ajay Shah ,Louisiana State University ,Physician Group ,Regional Medical Center ,Human Services ,Biomedical Advanced Research ,Franciscan Missionaries Of Our Lady Health System ,Lake Health ,Sepsis Alliance ,Twitter ,Lake Regional Medical Center ,Research At Our Lady ,Health Sciences Center ,Radius Global Market Research ,Development Authority ,Department Of Health ,Administration For Strategic Preparedness ,Centers For Medicare Medicaid Services ,Holliso Neal ,Medical Director ,Critical Care Physician ,Medicaid Services ,Franciscan Missionaries ,Lady Health System ,Louisiana State ,Strategic Preparedness ,Capital Region ,Awareness Study Summary Report ,Lsu Health Sciences Center ,Awake Health ,Emergency Department ,Our Lady Of The Lake Regional Medical Center ,Detection Technologies ,Medical Center ,Sepsis ,Operational Excellence ,Rapid Diagnosis ,